Rational design for cytosolic delivery of nucleoside monphosphates : “SATE” and “DTE” as enzyme-labile transient phosphate protecting groups
- 15 March 2001
- journal article
- Published by Elsevier
- Vol. 3 (12) , 2521-2526
- https://doi.org/10.1016/s0960-894x(01)80709-5
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Nucleoside Analogues as Chemotherapeutic Agents: A ReviewNucleosides and Nucleotides, 1992
- Activities of 3'-azido-3'-deoxythymidine nucleotide dimers in primary lymphocytes infected with human immunodeficiency virus type 1Antimicrobial Agents and Chemotherapy, 1990
- Synthesis and biological properties of novel phosphotriesters: a new approach to the introduction of biologically active nucleotides into cellsJournal of Medicinal Chemistry, 1990
- Nucleotide Dimers Suppress HIV Expression In VitroAIDS Research and Human Retroviruses, 1988
- Metabolism of 6-methylthiopurine ribonucleoside 5′-phosphateBiochemical Pharmacology, 1971
- Nucleic Acids. III. Antiviral Activity of Nucleotides and Dinucleoside Phosphates Containing ara-CytidineJournal of Medicinal Chemistry, 1967
- Nucleic Acids. II. Cytotoxicity Studies with Nucleotides and Dinucleoside Phosphates Containing ara-CytidineJournal of Medicinal Chemistry, 1967
- Nucleic Acids. I. The Synthesis of Nucleotides and Dinucleoside Phosphates Containing ara-CytidineJournal of Medicinal Chemistry, 1967
- Synthesis of Potential Anticancer Agents. XXVIII. Simple Esters of 6-Mercaptopurine Ribonucleotide2The Journal of Organic Chemistry, 1961
- THE UTILIZATION OF NUCLEOTIDES BY THE MAMMALPublished by Elsevier ,1956